KI MAY TUNG: Open Payments
NPI 1326195934 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $341 · 2025 $1,611
Food & beverage: $1,412Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $641 |
| Astellas Pharma US Inc | 4 | $521 |
| Exelixis Inc. | 1 | $127 |
| PFIZER INC. | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| ABBVIE INC. | 2 | $39 |
| Caris MPI, Inc. | 1 | $37 |
Products named: RYBREVANT, Xtandi, ERLEADA, Vyloy, CABOMETYX, TALZENNA, Padcev, IMDELLTRA (AMG757).
Industry payments across HI — which companies pay providers there.
